Supplemental material
Open access
3,232
Views
15
CrossRef citations to date
0
Altmetric
Reports
Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV
Wen Jianga Department of Antibody Discovery and Development, Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, ChinaCorrespondence[email protected]
View further author information
, View further author information
Junchao Wangb School of Life Sciences, Anhui University, Hefei, ChinaView further author information
, Shasha Jiaoa Department of Antibody Discovery and Development, Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, China;c Department of Antibody Discovery, Beijing Kohnoor Science & Technology Co. Ltd, Beijing, ChinaView further author information
, Chenjian Gud Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, ChinaView further author information
, Wei Xud Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, ChinaView further author information
, Ben Chena Department of Antibody Discovery and Development, Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, ChinaView further author information
, Rongjuan Wanga Department of Antibody Discovery and Development, Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, China;c Department of Antibody Discovery, Beijing Kohnoor Science & Technology Co. Ltd, Beijing, ChinaView further author information
, Huilin Chena Department of Antibody Discovery and Development, Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, ChinaView further author information
, Youhua Xied Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Department of Medical Microbiology and Parasitology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, ChinaView further author information
, An Wanga Department of Antibody Discovery and Development, Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, ChinaView further author information
, Gang Lia Department of Antibody Discovery and Development, Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, ChinaView further author information
, Dadi Zenga Department of Antibody Discovery and Development, Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, China;c Department of Antibody Discovery, Beijing Kohnoor Science & Technology Co. Ltd, Beijing, ChinaView further author information
, Jinchao Zhanga Department of Antibody Discovery and Development, Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, ChinaView further author information
, Min Zhangb School of Life Sciences, Anhui University, Hefei, ChinaView further author information
, Shuang Wanga Department of Antibody Discovery and Development, Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, China;c Department of Antibody Discovery, Beijing Kohnoor Science & Technology Co. Ltd, Beijing, ChinaCorrespondence[email protected]
View further author information
, View further author information
Mingzhu Wangb School of Life Sciences, Anhui University, Hefei, ChinaView further author information
& Xun Guia Department of Antibody Discovery and Development, Mabwell (Shanghai) Bioscience Co., Ltd, Shanghai, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-5070-3527View further author information
Article: 1953683
|
Received 15 Mar 2021, Accepted 06 Jul 2021, Published online: 27 Jul 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.